Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dendritic cells are specialized antigen-presenting cells that play a central role in initiating and regulating adaptive immune responses[7][9]. Upon encountering pathogens or foreign antigens in peripheral tissues, dendritic cells internalize and process these antigens, then migrate to lymph nodes where they present antigen-derived peptides on their surface via MHC molecules. - MHC class II presents antigens to CD4+ helper T-cells, which orchestrate immune responses through cytokine secretion and help activate other immune cells[2][7]. - MHC class I, via cross-presentation, enables activation of CD8+ cytotoxic T-cells, crucial for killing infected or tumor cells[1][3][5]. Dendritic cells also provide important co-stimulatory signals required for full T-cell activation. The interplay between dendritic cells and T-cells is essential for immunity against infections and cancer, as well as induction of tolerance to prevent autoimmunity[8][9]. Multiple molecular mechanisms, including endocytic processing, peptide loading, and co-receptor interactions (e.g., CD80, CD86, CD40), are involved in this process[1][7][8].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Antigen presentation by dendritic cell leading to activation of CD4+ and CD8+ T-cell.